MARKET

USNA

USNA

Usana Hlth Sci
NYSE

Real-time Quotes | Nasdaq Last Sale

82.54
-0.01
-0.01%
After Hours: 82.54 0 0.00% 16:00 08/07 EDT
OPEN
82.73
PREV CLOSE
82.55
HIGH
83.03
LOW
81.84
VOLUME
96.58K
TURNOVER
--
52 WEEK HIGH
92.26
52 WEEK LOW
43.01
MARKET CAP
1.73B
P/E (TTM)
16.31
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average USNA stock price target is 92.50 with a high estimate of 100.00 and a low estimate of 85.00.

EPS

USNA News

More
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
Zacks · 3d ago
USANA Health Science Trying To Close In On Key Technical Benchmark
USANA Health Science shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Investor's Business Daily · 5d ago
Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?
Is (USNA) Outperforming Other Medical Stocks This Year?
Zacks · 07/31 15:30
USANA Health Sciences, Inc. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 07/24 17:57
USANA Health Sciences Inc (USNA) Q2 2020 Earnings Call Transcript
At this time, I'd like to turn the conference over to Mr. Patrique Richards, Executive Director of Investor Relations and Business Development. Good morning and thank you for joining us to review our second quarter.
Motley Fool · 07/22 19:00
USANA Health Q2 earnings up 45%, guidance raised
USANA Health Sciences (NYSE:USNA) Q2 results: Net sales: $259.0M (+1.2%). Net income: EPS: $1.32 (+45.1%). Active customers: 599K (+7.9%). 2020 guidance: N
seekingalpha · 07/22 01:49
USANA Health Sciences EPS beats by $0.13, misses on revenue
USANA Health Sciences (NYSE:USNA): Q2 GAAP EPS of $1.32 beats by $0.13. Revenue of $258.99M (+1.2% Y/Y) misses by $8.81M. Press Release
seekingalpha · 07/22 01:26
USANA Health Sciences (USNA) Tops Q2 Earnings Estimates
USANA Health (USNA) delivered earnings and revenue surprises of 10.92% and -3.29%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/21 21:45

Industry

Personal Products
+0.09%
Personal & Household Products & Services
-0.80%

Hot Stocks

Symbol
Price
%Change

About USNA

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
More

Webull offers kinds of USANA Health Sciences, Inc. stock information, including NYSE:USNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, USNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading USNA stock methods without spending real money on the virtual paper trading platform.